Silencing of HIV-1 by AgoshRNA molecules

被引:0
|
作者
E Herrera-Carrillo
A Harwig
B Berkhout
机构
[1] Laboratory of Experimental Virology,Department of Medical Microbiology
[2] Center for Infection and Immunity Amsterdam (CINIMA),undefined
[3] Academic Medical Center,undefined
[4] University of Amsterdam,undefined
来源
Gene Therapy | 2017年 / 24卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
RNA interference (RNAi) is a sequence-specific gene silencing mechanism that is triggered by the expression of a short hairpin RNA (shRNA). shRNA molecules enter the RNAi pathway at the Dicer processing step. Recent studies indicated that the cellular microRNA miR-451 is not recognized by Dicer, but that it is processed instead by the Argonaute 2 (Ago2) protein. Subsequently, Dicer-independent shRNAs were described that rely on Ago2 for processing, as well as the subsequent silencing step. We called these AgoshRNA molecules because they depend on Ago2 both for maturation and activation. Processing of an AgoshRNA yields only a single active RNA strand, thus reducing the chance of adverse off-target effects induced by the passenger strand of regular shRNAs. In this study, we converted several anti-HIV-1 shRNAs into AgoshRNAs. Seven of the 21 designed AgoshRNAs were potent anti-HIV molecules, although their RNAi activity is generally somewhat reduced compared with the matching shRNAs. The AgoshRNA candidates revealed no cellular toxicity. This may relate to the absence of passenger strand expression, which was verified for these AgoshRNA candidates. Furthermore, we demonstrate that a toxic shRNA can be converted into a non-toxic AgoshRNA.
引用
收藏
页码:453 / 461
页数:8
相关论文
共 50 条
  • [1] Silencing of HIV-1 by AgoshRNA molecules
    Herrera-Carrillo, E.
    Harwig, A.
    Berkhout, B.
    GENE THERAPY, 2017, 24 (08) : 453 - 461
  • [2] Novel AgoshRNA molecules for silencing of the CCR5 co-receptor for HIV-1 infection
    Herrera-Carrillo, Elena
    Ben Berkhout
    PLOS ONE, 2017, 12 (05):
  • [3] HIV: Silencing HIV-1
    Buckland J.
    Nature Reviews Immunology, 2002, 2 (7) : 458 - 458
  • [4] Silencing HIV-1
    Buckland, J
    NATURE REVIEWS IMMUNOLOGY, 2002, 2 (07) : 458 - 459
  • [5] Silencing HIV-1 in vivo
    Kirchhoff, Frank
    CELL, 2008, 134 (04) : 566 - 568
  • [6] HIV-1 Remission: Accelerating the Path to Permanent HIV-1 Silencing
    Lyons, Danielle E.
    Kumar, Priti
    Roan, Nadia R.
    Defechereux, Patricia A.
    Feschotte, Cedric
    Lange, Ulrike C.
    Murthy, Niren
    Sameshima, Pauline
    Verdin, Eric
    Ake, Julie A.
    Parsons, Matthew S.
    Nath, Avindra
    Gianella, Sara
    Smith, Davey M.
    Kallas, Esper G.
    Villa, Thomas J.
    Strange, Richard
    Mwesigwa, Betty
    Furler O'Brien, Robert L.
    Nixon, Douglas F.
    Ndhlovu, Lishomwa C.
    Valente, Susana T.
    Ott, Melanie
    VIRUSES-BASEL, 2023, 15 (11):
  • [7] HIV-1 induces RNA silencing
    Flores G.
    Genome Biology, 6 (1)
  • [8] HIV-1 induces RNA silencing
    Flores, G
    SCIENTIST, 2005, 19 (11): : 28 - 28
  • [9] PTEN Mediates the Silencing of Unintegrated HIV-1 DNA
    Phan, An Thanh
    Zhu, Yiping
    VIRUSES-BASEL, 2024, 16 (02):
  • [10] Silencing of HIV-1 with RNA interference: A multiple shRNA approach
    ter Brake, Olivier
    von Eije, Karin J.
    Jan-Tinus, Westerink
    Schopman, Nick C.
    Berkhout, Ben
    HUMAN GENE THERAPY, 2008, 19 (10) : 1169 - 1169